» Articles » PMID: 30646132

Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016

Overview
Journal JAMA Netw Open
Specialty General Medicine
Date 2019 Jan 16
PMID 30646132
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Attention-deficit/hyperactivity disorder (ADHD) is common in US children and adolescents. It is important to understand the most recent prevalence of ADHD and its long-term trends over the past decades.

Objective: To estimate the prevalence of diagnosed ADHD and 20-year trends from 1997 to 2016 among US children and adolescents using nationally representative data.

Design, Setting, And Participants: In this population-based, cross-sectional survey study (National Health Interview Survey), surveys were conducted annually from 1997 to 2016. A total of 186 457 children and adolescents aged 4 to 17 years from 1997 to 2016 were included in this analysis. Data were collected through in-person household interviews with a parent or guardian. The data analysis was performed in January 2018.

Main Outcomes And Measures: Attention-deficit/hyperactivity disorder diagnosed by a physician or other health care professional.

Results: Among the included 186 457 children and adolescents (96 017 boys [51.5%], 51 350 Hispanic [27.5%], 91 374 non-Hispanic white [49.0%], 28 808 non-Hispanic black [15.5%], 14 925 non-Hispanic other race [8.0%]), 14 704 children and adolescents (7.9%; 10 536 boys [71.7%], 2497 Hispanic [17.0%], 9010 non-Hispanic white [61.3%], 2328 non-Hispanic black [15.8%], and 869 non-Hispanic other race [5.9%]) were reported to have ever been diagnosed with ADHD. The weighted prevalence of diagnosed ADHD was 10.2% (95% CI, 9.6%-10.8%) in 2015-2016. There were significant sex and racial/ethnic disparities in the prevalence of diagnosed ADHD. The prevalence was 14.0% (95% CI, 13.1%-15.0%) in boys and 6.3% (95% CI, 5.6%-7.0%) in girls, 6.1% (95% CI, 5.2%-7.0%) in Hispanic individuals, 12.0% (95% CI, 11.1%-12.9%) in non-Hispanic white individuals, and 12.8% (95% CI, 11.0%-14.5%) in non-Hispanic black individuals. Over the 20-year period, the estimated prevalence of diagnosed ADHD in US children and adolescents increased from 6.1% in 1997-1998 to 10.2% in 2015-2016 (P for trend <.001). All subgroups by age, sex, race/ethnicity, family income, and geographic regions showed a significant increase in the prevalence from 1997-1998 to 2015-2016.

Conclusions And Relevance: This study's findings suggest that among US children and adolescents, the estimated prevalence of diagnosed ADHD increased significantly between 1997-1998 and 2015-2016. This study suggests that additional research is needed to better understand the cause of this apparent rise in prevalence.

Citing Articles

The role of sleep disturbances in the onset and maintenance of psychiatric disorders in childhood and adolescence: A review of subjective and polysomnographic findings.

Lunsford-Avery J, Falls A, Cary S, Duke N Curr Sleep Med Rep. 2025; 10(3):301-313.

PMID: 40061447 PMC: 11884501. DOI: 10.1007/s40675-024-00300-0.


Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database.

Wu L, Zhao D, Lan Y, Jin L, Yang L BMC Pharmacol Toxicol. 2025; 26(1):38.

PMID: 39980035 PMC: 11844164. DOI: 10.1186/s40360-025-00868-5.


Association between maternal smoking during pregnancy and developmental disabilities in US children and adolescents: A cross-sectional study from NHANES.

Miao H, Zhang C, Qian J, Jing H, Nan H, Li S Tob Induc Dis. 2025; 23.

PMID: 39931131 PMC: 11808298. DOI: 10.18332/tid/200339.


Association between some environmental risk factors and attention-deficit hyperactivity disorder among children in Egypt: a case-control study.

Hussein R, Refai R, El-Zoka A, Azouz H, Hussein M Ital J Pediatr. 2025; 51(1):19.

PMID: 39875928 PMC: 11776284. DOI: 10.1186/s13052-025-01843-w.


Beyond the Brain: Attention Deficit/Hyperactivity Disorder and the Gut-Brain Axis.

Gandhi D, Pande D, Harikrishna A, Advilkar A, Basavan I, Ansari R Cureus. 2025; 16(12):e76291.

PMID: 39850178 PMC: 11754923. DOI: 10.7759/cureus.76291.


References
1.
Biederman J, Petty C, Monuteaux M, Fried R, Byrne D, Mirto T . Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry. 2010; 167(4):409-17. DOI: 10.1176/appi.ajp.2009.09050736. View

2.
Sciberras E, Mulraney M, Silva D, Coghill D . Prenatal Risk Factors and the Etiology of ADHD-Review of Existing Evidence. Curr Psychiatry Rep. 2017; 19(1):1. DOI: 10.1007/s11920-017-0753-2. View

3.
Verkuijl N, Perkins M, Fazel M . Childhood attention-deficit/hyperactivity disorder. BMJ. 2015; 350:h2168. DOI: 10.1136/bmj.h2168. View

4.
Danielson M, Visser S, Gleason M, Peacock G, Claussen A, Blumberg S . A National Profile of Attention-Deficit Hyperactivity Disorder Diagnosis and Treatment Among US Children Aged 2 to 5 Years. J Dev Behav Pediatr. 2017; 38(7):455-464. PMC: 5598086. DOI: 10.1097/DBP.0000000000000477. View

5.
Akinbami L, Liu X, Pastor P, Reuben C . Attention deficit hyperactivity disorder among children aged 5-17 years in the United States, 1998-2009. NCHS Data Brief. 2011; (70):1-8. View